The interplay of gut-microbiome between infection and inflammation

61.4K

views

134

authors

18

articles

Editorial

06 June 2024

Editorial: The interplay of gut-microbiome between infection and inflammation

Piyush Baindara

and

Santi M. Mandal

1,312 views

0 citations

Editors

2

Piyush Baindara

University of Missouri

Santi M. Mandal

Indian Institute of Technology Kharagpur

Impact

About

Gut microbiome has become the greatest attraction of the research community in the recent past due to their diverse compositions and involvement in the regulation of human health and disease. With the development of high-throughput genomic analysis and other scientific advances, the gut microbiome has emerged as a potential therapeutic target for both infectious and autoimmune diseases. Especially, respiratory infections such as tuberculosis and COVID-19 have been shown to have a major impact on disease pathogenesis caused by gut dysbiosis which further affects the regulation of the gut-lung axis and contributes to disease progression. On the other hand, gut dysbiosis has been reported as a key player in multiple chronic diseases including gastrointestinal metabolic, neurological, cardiovascular, and respiratory inflammatory disease that includes diabetes, obesity, intestinal bowel disease, and cancer, etc. Despite, the known involvement, the mechanistic role of gut microbiota in disease pathogenesis is still undermined. The current research topic is focused on the mechanistic interplay of gut microbiota between infection and inflammation and thus overall disease progression. Strategies to overcome gut dysbiosis, gut microbiome transfer, the influence of antibiotics on the gut microbiome, modulation of gut microbiome via drug-repurposing, and host-directed therapies targeting the gut microbiome will also be discussed.

Gut microbiome has become the greatest attraction of the research community in the recent past due to their diverse compositions and involvement in the regulation of human health and disease. With the development of high-throughput genomic analysis and other scientific advances, the gut microbiome has emerged as a potential therapeutic target for both infectious and autoimmune diseases. Especially, respiratory infections such as tuberculosis and COVID-19 have been shown to have a major impact on disease pathogenesis caused by gut dysbiosis which further affects the regulation of the gut-lung axis and contributes to disease progression. On the other hand, gut dysbiosis has been reported as a key player in multiple chronic diseases including gastrointestinal metabolic, neurological, cardiovascular, and respiratory inflammatory disease that includes diabetes, obesity, intestinal bowel disease, and cancer, etc. Despite, the known involvement, the mechanistic role of gut microbiota in disease pathogenesis is still undermined. The current research topic is focused on the mechanistic interplay of gut microbiota between infection and inflammation and thus overall disease progression. Strategies to overcome gut dysbiosis, gut microbiome transfer, the influence of antibiotics on the gut microbiome, modulation of gut microbiome via drug-repurposing, and host-directed therapies targeting the gut microbiome will also be discussed.

Download ebook

Share

Editors

Piyush Baindara

University of Missouri

Santi M. Mandal

Indian Institute of Technology Kharagpur

Impact

61,391 Total views

43,194 Article views

16,818 Article downloads

1,379 Topic views

Published In

Journal Thumbnail

Frontiers in Cellular and Infection Microbiology

Intestinal Microbiome

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic